Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1353913rdf:typepubmed:Citationlld:pubmed
pubmed-article:1353913lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:1353913lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:1353913lifeskim:mentionsumls-concept:C0522537lld:lifeskim
pubmed-article:1353913lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:1353913lifeskim:mentionsumls-concept:C1328709lld:lifeskim
pubmed-article:1353913pubmed:issue2lld:pubmed
pubmed-article:1353913pubmed:dateCreated1992-9-8lld:pubmed
pubmed-article:1353913pubmed:abstractTextAnti-CD2 monoclonal antibodies (mAb) were used to influence graft survival in two transplantation models. Xenogeneic rat islets were transplanted intraportally into mice. Anti-CD2 mAb prolonged xenograft survival and was synergistic with UVB irradiation in prolonging survival. Anti-CD2 mAb was also more potent than an anti-CD4 mAb in this model. Allogeneic cardiac grafts were transplanted across an entire H-2 difference and anti-CD2 mAb prolonged allograft survival in a dose-dependent fashion. Kinetic experiments revealed that anti-CD2 mAb was most potent when administered at the time of allografting. A delay in administration of mAb markedly reduced its immunosuppressive effects. Furthermore, additional doses of mAb given after the initial doses provided no increased immunosuppression and anti-CD2 mAbs did not delay rejection of second-set allografts. These findings support the notion that anti-CD2 mAbs interfere with afferent immunity and that CD2 is most important during the initial steps of an immune response. Investigation of the effect of anti-CD2 mAb on cellular immune functions demonstrated, in agreement with previous results, that it caused antigenic down-modulation of CD2 with relative sparing of CD3, CD4, and CD8 cell surface expression. Concomitantly the MLR, CTL, and NK responses were suppressed.lld:pubmed
pubmed-article:1353913pubmed:languageenglld:pubmed
pubmed-article:1353913pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1353913pubmed:citationSubsetIMlld:pubmed
pubmed-article:1353913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1353913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1353913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1353913pubmed:statusMEDLINElld:pubmed
pubmed-article:1353913pubmed:monthAuglld:pubmed
pubmed-article:1353913pubmed:issn0041-1337lld:pubmed
pubmed-article:1353913pubmed:authorpubmed-author:BrombergJ SJSlld:pubmed
pubmed-article:1353913pubmed:authorpubmed-author:ChavinK DKDlld:pubmed
pubmed-article:1353913pubmed:authorpubmed-author:LauH THTlld:pubmed
pubmed-article:1353913pubmed:issnTypePrintlld:pubmed
pubmed-article:1353913pubmed:volume54lld:pubmed
pubmed-article:1353913pubmed:ownerNLMlld:pubmed
pubmed-article:1353913pubmed:authorsCompleteYlld:pubmed
pubmed-article:1353913pubmed:pagination286-91lld:pubmed
pubmed-article:1353913pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:meshHeadingpubmed-meshheading:1353913-...lld:pubmed
pubmed-article:1353913pubmed:year1992lld:pubmed
pubmed-article:1353913pubmed:articleTitleProlongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies.lld:pubmed
pubmed-article:1353913pubmed:affiliationDepartment of Surgery, Medical University of South Carolina, Charleston 29425.lld:pubmed
pubmed-article:1353913pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1353913pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1353913pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1353913lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1353913lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1353913lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1353913lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1353913lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1353913lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1353913lld:pubmed